DR. SCOTT C BRUN, MD
Medical Practice in North Chicago, IL
License number
Illinois 036095736
Category
Medical Practice
Type
Ophthalmology
Address
Address
2
1 N Waukegan Rd Dept R435 BLDG AP30-3, North Chicago, IL 60064
31048 Prairie Ridge Rd, Green Oaks, IL 60048
31048 Prairie Ridge Rd, Green Oaks, IL 60048
Phone
(847) 935-1293
(847) 938-3711 (Fax)
(847) 938-3711 (Fax)
Personal information
See more information about SCOTT C BRUN at radaris.comName
Address
Phone
31048 Prairie Ridge Rd, Libertyville, IL 60048
31048 Prairie Ridge Rd, Chicago, IL 60634
31048 Prairie Ridge Rd, Libertyville, IL 60048
Professional information
Scott Curtis Brun, North Chicago IL
Specialties:
Ophthalmology
Work:
Abbott Laboratories
200 Abbott Park Rd, North Chicago, IL 60064
200 Abbott Park Rd, North Chicago, IL 60064
Education:
Johns Hopkins University (1993)
Dr. Scott C Brun, Libertyville IL - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
31048 Prairie Ridge Rd, Libertyville 60048
Certifications:
Ophthalmology, 1999
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Johns Hopkins University / School of Medicine
Graduated: 1993
Franklin Sq Med Ctr
Mass Eye and Ear Infirm-Harvard Med Sch
Johns Hopkins University / School of Medicine
Graduated: 1993
Franklin Sq Med Ctr
Mass Eye and Ear Infirm-Harvard Med Sch
Methods For Treating Hcv
US Patent:
2013010, Apr 25, 2013
Filed:
Oct 19, 2012
Appl. No.:
13/656024
Inventors:
Rajeev M. Menon - Buffalo Grove IL, US
Amit Khatri - Waukegan IL, US
Sven Mensing - Mannheim, DE
Sandeep Dutta - Gurnee IL, US
Daniel E. Cohen - Wilmette IL, US
Thomas J. Podsadecki - Chicago IL, US
Scott C. Brun - Green Oaks IL, US
Walid M. Awni - Green Oaks IL, US
Emily O. Dumas - Libertyville IL, US
Cheri E. Klein - Northbrook IL, US
Amit Khatri - Waukegan IL, US
Sven Mensing - Mannheim, DE
Sandeep Dutta - Gurnee IL, US
Daniel E. Cohen - Wilmette IL, US
Thomas J. Podsadecki - Chicago IL, US
Scott C. Brun - Green Oaks IL, US
Walid M. Awni - Green Oaks IL, US
Emily O. Dumas - Libertyville IL, US
Cheri E. Klein - Northbrook IL, US
Assignee:
AbbVie Inc. - North Chicago IL
International Classification:
A61K 31/7056, A61P 31/14
US Classification:
514 43
Abstract:
The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin.
Methods For Treating Hcv
US Patent:
2013010, Apr 25, 2013
Filed:
Oct 19, 2012
Appl. No.:
13/656012
Inventors:
Rajeev M. Menon - Buffalo Grove IL, US
Amit Khatri - Waukegan IL, US
Sven Mensing - Mannheim, DE
Sandeep Dutta - Gurnee IL, US
Daniel E. Cohen - Wilmette IL, US
Thomas J. Podsadecki - Chicago IL, US
Scott C. Brun - Green Oaks IL, US
Walid M. Awni - Green Oaks IL, US
Emily O. Dumas - Libertyville IL, US
Cheri E. Klein - Northbrook IL, US
Amit Khatri - Waukegan IL, US
Sven Mensing - Mannheim, DE
Sandeep Dutta - Gurnee IL, US
Daniel E. Cohen - Wilmette IL, US
Thomas J. Podsadecki - Chicago IL, US
Scott C. Brun - Green Oaks IL, US
Walid M. Awni - Green Oaks IL, US
Emily O. Dumas - Libertyville IL, US
Cheri E. Klein - Northbrook IL, US
Assignee:
ABBVIE INC. - North Chicago IL
International Classification:
A61K 38/07, A61P 31/14, A61K 31/7068, A61K 31/7072, A61K 38/06
US Classification:
514 43, 514 51, 514 48, 514 49
Abstract:
The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to a subject an effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), and an inhibitor of cytochrome P450 (e.g., ritonavir).
Methods For Treating Hcv
US Patent:
2014005, Feb 27, 2014
Filed:
Jul 5, 2013
Appl. No.:
13/935987
Inventors:
Rajeev M. MENON - Buffalo Grove IL, US
Amit KHATRI - Waukegan IL, US
Sven MENSING - Mannheim, DE
Sandeep DUTTA - Gurnee IL, US
Daniel E. COHEN - Wilmette IL, US
Scott C. BRUN - Green Oaks IL, US
Walid M. AWNI - Green Oaks IL, US
Emily O. DUMAS - Libertyville IL, US
Cheri E. KLEIN - Northbrook IL, US
Thomas J. PODSADECKI - Chicago IL, US
Amit KHATRI - Waukegan IL, US
Sven MENSING - Mannheim, DE
Sandeep DUTTA - Gurnee IL, US
Daniel E. COHEN - Wilmette IL, US
Scott C. BRUN - Green Oaks IL, US
Walid M. AWNI - Green Oaks IL, US
Emily O. DUMAS - Libertyville IL, US
Cheri E. KLEIN - Northbrook IL, US
Thomas J. PODSADECKI - Chicago IL, US
Assignee:
AbbVie Inc. - North Chicago IL
International Classification:
A61K 38/12, A61K 31/4184, A61K 31/427, A61K 31/7072, A61K 31/513, A61K 38/06
US Classification:
514 43, 514 51
Abstract:
The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to a subject an effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), and an inhibitor of cytochrome P450 (e.g., ritonavir).
Methods For Treating Hcv
US Patent:
2014002, Jan 23, 2014
Filed:
Jul 5, 2013
Appl. No.:
13/935983
Inventors:
Rajeev M. MENON - Buffalo Grove IL, US
Amit KHATRI - Waukegan IL, US
Sven MENSING - Mannheim, DE
Sandeep DUTTA - Gurnee IL, US
Daniel E. COHEN - Wilmette IL, US
Scott C. BRUN - Green Oaks IL, US
Walid M. AWNI - Green Oaks IL, US
Emily O. DUMAS - Libertyville IL, US
Cheri E. KLEIN - Northbrook IL, US
Thomas J. PODSADECKI - Chicago IL, US
Amit KHATRI - Waukegan IL, US
Sven MENSING - Mannheim, DE
Sandeep DUTTA - Gurnee IL, US
Daniel E. COHEN - Wilmette IL, US
Scott C. BRUN - Green Oaks IL, US
Walid M. AWNI - Green Oaks IL, US
Emily O. DUMAS - Libertyville IL, US
Cheri E. KLEIN - Northbrook IL, US
Thomas J. PODSADECKI - Chicago IL, US
Assignee:
AbbVie Inc. - North Chicago IL
International Classification:
A61K 38/12, A61K 31/7056, A61K 31/427, A61K 31/513, A61K 38/05
US Classification:
514 43, 514 43
Abstract:
The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin.
Methods For Treating Hcv
US Patent:
8492386, Jul 23, 2013
Filed:
Sep 4, 2012
Appl. No.:
13/603006
Inventors:
Barry M. Bernstein - Mequon WI, US
Rajeev M. Menon - Buffalo Grove IL, US
Amit Khatri - Waukegan IL, US
Sven Mensing - Mannheim, DE
Sandeep Dutta - Gurnee IL, US
Daniel E. Cohen - Wilmette IL, US
Thomas J. Podsadecki - Chicago IL, US
Scott C. Brun - Green Oaks IL, US
Walid M. Awni - Green Oaks IL, US
Emily O. Dumas - Libertyville IL, US
Cheri E. Klein - Northbrook IL, US
Rajeev M. Menon - Buffalo Grove IL, US
Amit Khatri - Waukegan IL, US
Sven Mensing - Mannheim, DE
Sandeep Dutta - Gurnee IL, US
Daniel E. Cohen - Wilmette IL, US
Thomas J. Podsadecki - Chicago IL, US
Scott C. Brun - Green Oaks IL, US
Walid M. Awni - Green Oaks IL, US
Emily O. Dumas - Libertyville IL, US
Cheri E. Klein - Northbrook IL, US
Assignee:
AbbVie Inc. - North Chicago IL
International Classification:
A61K 31/4965, A61K 31/33, A61K 31/505, A61K 31/47, A61K 31/415, A61K 31/40, A61K 31/675
US Classification:
51425505, 514183, 514269, 514314, 514397, 514309, 514394, 514422, 514 81
Abstract:
The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to a subject an effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), and an inhibitor of cytochrome P450 (e. g. , ritonavir).
Methods For Treating Hcv
US Patent:
2013010, Apr 25, 2013
Filed:
Sep 4, 2012
Appl. No.:
13/603022
Inventors:
Barry M. Bernstein - Mequon WI, US
Rajeev M. Menon - Buffalo Grove IL, US
Amit Khatri - Waukegan IL, US
Sven Mensing - Mannheim, DE
Sandeep Dutta - Gurnee IL, US
Daniel E. Cohen - Wilmette IL, US
Thomas J. Podsadecki - Chicago IL, US
Scott C. Brun - Green Oaks IL, US
Walid M. Awni - Green Oaks IL, US
Emily O. Dumas - Libertyville IL, US
Cheri E. Klein - Northbrook IL, US
Rajeev M. Menon - Buffalo Grove IL, US
Amit Khatri - Waukegan IL, US
Sven Mensing - Mannheim, DE
Sandeep Dutta - Gurnee IL, US
Daniel E. Cohen - Wilmette IL, US
Thomas J. Podsadecki - Chicago IL, US
Scott C. Brun - Green Oaks IL, US
Walid M. Awni - Green Oaks IL, US
Emily O. Dumas - Libertyville IL, US
Cheri E. Klein - Northbrook IL, US
Assignee:
ABBVIE INC. - North Chicago IL
International Classification:
A61K 31/7056, A61P 31/14, A61K 38/07
US Classification:
514 43, 514 43
Abstract:
The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin.
Methods For Treating Hcv
US Patent:
2013007, Mar 21, 2013
Filed:
Sep 17, 2012
Appl. No.:
13/621454
Inventors:
Barry M. Bernstein - Mequon WI, US
Scott C. Brun - Green Oaks IL, US
Scott C. Brun - Green Oaks IL, US
Assignee:
ABBVIE INC. - North Chicago IL
International Classification:
A61K 31/427, A61P 31/14
US Classification:
514365
Abstract:
The present invention features interferon-free therapies for the treatment of HCV. The therapies comprise administering Compound I (or a pharmaceutically acceptable salt thereof) and another anti-HCV agent. Preferably, the therapies are both interferon- and ribavirin-free.